The Alberta government says it is now allowing children living with cystic fibrosis (CF) aged six to 11 access to Trikafta..Previously, the drug was available to Albertans 12-years-old and older. The medication is now approved for use by younger children and is covered in Alberta..CF is an inherited disorder that causes severe damage to the lungs, digestive system and other organs in the body. Currently, there is no cure for CF..“Alberta was among the first provinces and territories to provide older children and adults with access to Trikafta," Minister of Health Jason Copping said.."Once again, Alberta’s government is leading the way by quickly making this transformative medication available to younger children, giving them the same opportunity to realize an improved quality of life.”.The use of Trikafta to treat children aged six to 11 was approved by Health Canada on April 19 and recommended for listing by the Canadian Agency for Drugs and Technologies in Health on July 6..According to the FDA the drug improves lung function by allowing air to move easier. However, it may cause serious side effects including increased liver enzymes and cataracts. The most commonly reported side effects associated with the drug are headache, upper respiratory infections, abdominal pain, diarrhea, rash and elevated liver enzymes..“This news will change the trajectory of the disease and the future for many children in Alberta who live with cystic fibrosis," President and CEO of Cystic Fibrosis Canada Kelly Grover said.."Alberta was one of the first provinces to fund the drug for those 12 years of age and older last year, and has continued to recognize Trikafta’s extraordinary, transformative value by expanding coverage of Trikafta to include children ages six to 11.".Alberta’s government provided Albertans 12 years of age and older, who meet eligibility criteria, with access to Trikafta in September 2021. After extensive consideration of the needs of Albertans living with cystic fibrosis, the province chose to provide broader access so the majority can receive treatment with the drug..The government also provides coverage for CF drugs Kalydeco and Orkambi for those meeting eligibility criteria.."We celebrate this news alongside our CF community in Alberta, which has worked tirelessly for this day.” Grover said.
The Alberta government says it is now allowing children living with cystic fibrosis (CF) aged six to 11 access to Trikafta..Previously, the drug was available to Albertans 12-years-old and older. The medication is now approved for use by younger children and is covered in Alberta..CF is an inherited disorder that causes severe damage to the lungs, digestive system and other organs in the body. Currently, there is no cure for CF..“Alberta was among the first provinces and territories to provide older children and adults with access to Trikafta," Minister of Health Jason Copping said.."Once again, Alberta’s government is leading the way by quickly making this transformative medication available to younger children, giving them the same opportunity to realize an improved quality of life.”.The use of Trikafta to treat children aged six to 11 was approved by Health Canada on April 19 and recommended for listing by the Canadian Agency for Drugs and Technologies in Health on July 6..According to the FDA the drug improves lung function by allowing air to move easier. However, it may cause serious side effects including increased liver enzymes and cataracts. The most commonly reported side effects associated with the drug are headache, upper respiratory infections, abdominal pain, diarrhea, rash and elevated liver enzymes..“This news will change the trajectory of the disease and the future for many children in Alberta who live with cystic fibrosis," President and CEO of Cystic Fibrosis Canada Kelly Grover said.."Alberta was one of the first provinces to fund the drug for those 12 years of age and older last year, and has continued to recognize Trikafta’s extraordinary, transformative value by expanding coverage of Trikafta to include children ages six to 11.".Alberta’s government provided Albertans 12 years of age and older, who meet eligibility criteria, with access to Trikafta in September 2021. After extensive consideration of the needs of Albertans living with cystic fibrosis, the province chose to provide broader access so the majority can receive treatment with the drug..The government also provides coverage for CF drugs Kalydeco and Orkambi for those meeting eligibility criteria.."We celebrate this news alongside our CF community in Alberta, which has worked tirelessly for this day.” Grover said.
